Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Consensus Rating of “Hold” by Analysts
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has been assigned an average rating of “Hold” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target […]
More Stories
Speak Like a Pro in 2 Months with Lingoda’s Sprint Challenge – Join Now!
Language skills open many doors, be it for work, traveling, or personal growth. Confidence and speed in speaking come from...
Sowell Financial Services LLC Invests $629,000 in Arista Networks, Inc. (NYSE:ANET)
Sowell Financial Services LLC bought a new position in shares of Arista Networks, Inc. (NYSE:ANET – Free Report) in the...
Janney Montgomery Scott LLC Has $13.11 Million Holdings in Vanguard Small-Cap Growth ETF (NYSEARCA:VBK)
Janney Montgomery Scott LLC lessened its holdings in Vanguard Small-Cap Growth ETF (NYSEARCA:VBK – Free Report) by 10.6% during the...
Robertson Stephens Wealth Management LLC Decreases Stake in General Dynamics Corporation (NYSE:GD)
Robertson Stephens Wealth Management LLC trimmed its holdings in shares of General Dynamics Corporation (NYSE:GD – Free Report) by 9.0%...
Exchange Traded Concepts LLC Decreases Stock Position in CVS Health Corporation (NYSE:CVS)
Exchange Traded Concepts LLC cut its stake in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 17.0% in...
Robertson Stephens Wealth Management LLC Has $361,000 Stock Holdings in NIKE, Inc. (NYSE:NKE)
Robertson Stephens Wealth Management LLC decreased its stake in NIKE, Inc. (NYSE:NKE – Free Report) by 6.6% in the first...